| Name | Convatec Group |
|---|---|
| Epic | CTEC |
| Isin | GB00BD3VFW73 |
| Index | UK100 UK350 |
| Industry | Medical Equipment and Services |
| Latest share price | 237.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £4,858.00 | Debt ratio | n/a |
| Shares in issue | 2,049.79 | Debt-to-equity ratio | n/a |
| P/E ratio | 22.7 | Assets / equity ratio | n/a |
| Total dividends per share | 6.229¢ | Price to book value | n/a |
| Dividend yield | 2 | ROCE | 17.99 |
| Dividend cover | 2.15 | EPS growth | 6 |
| Earning per share | 6.4 | 52-week high / low | 213.40p / 293.40p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Final | 2024-04-25 | 2024-05-23 | 4.46¢ |
| Interim | 2023-08-17 | 2023-09-28 | 1.769¢ |
| Final | 2023-04-06 | 2023-05-25 | 4.33¢ |
| Interim | 2022-08-25 | 2022-10-06 | 1.717¢ |
| Final | 2022-03-31 | 2022-05-19 | 4.154¢ |
| Interim | 2021-09-02 | 2021-10-14 | 1.717¢ |
| Final | 2021-04-01 | 2021-05-13 | 3.983¢ |
| Interim | 2020-09-03 | 2020-10-15 | 1.717¢ |
| Final | 2020-04-02 | 2020-05-14 | 3.983¢ |
| Company name | Convatec Group |
|---|---|
| Address | 3 Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH |
| Telephone | +44 (0) 118 952 8100 |
| Website | http://www.convatecgroup.com |
| Director | Position |
|---|---|
| Mr Karim Bitar | CEO |
| Mr Jonny Mason | CFO |
| Dr John McAdam | Chairman |
| Mrs Margaret Ewing | Senior Independent Non-Executive Director |
| Mr Brian May | Independent Non-Executive Director |
| Mrs Heather Mason | Independent Non-Executive Director |
| Ms Kimberly Lody | Independent Non-Executive Director |
| Prof Constantin Coussios | Independent Non-Executive Director |
| Ms Sharon O'Keefe | Independent Non-Executive Director |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 2234.1 | 2149.5 | 2058.5 |
| Investments and other non-current assets | 22.9 | 30.7 | n/a |
| Total non-current assets | 2843.7 | 2702.7 | 2563.2 |
| Inventory / work in progress | 396.1 | 336.9 | 308.8 |
| Trade and other receivables | 333.7 | 339.3 | 323.5 |
| Cash and equivalents | 97.6 | 143.8 | 463.4 |
| Other current assets and asset held for resale | 42.6 | 69.3 | 15.1 |
| Total of all assets | 3713.7 | 3592 | 3674 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 536.4 | 533.1 | 569.2 |
| Long term liabilities | 1484.6 | 1449.2 | 1410 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 2021 | 1982.3 | 1979.2 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 1692.7 | 1609.7 | 1694.8 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 251.5 | 250.7 | 247 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -888.7 | -892.2 | -842 |
| Share premium account | 181 | 165.7 | 142.3 |
| Total equity | 1692.7 | 1609.7 | 1694.8 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 262.7 | 207.3 | 203.6 |
| Pre-tax profit | 167.4 | 81.9 | 151.3 |